The U.S. corporate bond market is bracing for a flood of supply from mergers and acquisitions in the second half of the year. Borrowers will have to pay up after a first-half deluge helped wreck spreads.
Sales of investment-grade bonds tied to M&A surged by 50% to $154 billion in the first half compared with the same period last year, driven by a slew of deals that included CVS Health Corp., Walmart Inc. and Bayer AG, according to data compiled by Bloomberg. That pickup in supply helped push spreads in the secondary market to the highest level in a year and a half.
The trend could continue for the next six months. There’s more than $1 trillion in pending M&A deals, according to Bloomberg Intelligence. Walt Disney Co. is said to be readying a $36 billion bridge loan to potentially buy Twenty-First Century Fox Inc. Conagra Brands Inc. agreed to buy Pinnacle Foods Inc., Microsoft Corp. is buying GitHub Inc., and the list goes on.
Any trend that affects high-grade corporate bonds could affect life insurers, because life insurers invest heavily in high-grade corporate bonds.
“There are some deals in the pipeline that people are watching very closely and that could certainly be impactful for the market,” said Jim Caron, a senior fixed-income portfolio manager at Morgan Stanley Investment Management. “Supply has been sort of the reason why spreads have been widening. That could be something that people get a little bit concerned about.”
Companies started showing more interest in M&A in June when AT&T won an antitrust ruling allowing the takeover of Time Warner Inc. Within a week, Bayer came forward with a $15 billion bond deal to finance its acquisition of Monsanto and two days later Walmart sold $16 billion to fund a stake in Flipkart. The supply helped boost the benchmark index of high-grade corporate bond spreads to the highest level since December 2016.